ArticleJournal of translational internal medicine2023

A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.